Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 10 studies | 27% ± 11% | |
| oligodendrocyte | 7 studies | 33% ± 10% | |
| macrophage | 6 studies | 27% ± 9% | |
| fibroblast | 6 studies | 23% ± 9% | |
| GABAergic neuron | 6 studies | 37% ± 19% | |
| glutamatergic neuron | 5 studies | 41% ± 21% | |
| ciliated cell | 5 studies | 25% ± 7% | |
| oligodendrocyte precursor cell | 5 studies | 37% ± 14% | |
| smooth muscle cell | 5 studies | 20% ± 4% | |
| astrocyte | 5 studies | 40% ± 12% | |
| interneuron | 5 studies | 42% ± 21% | |
| epithelial cell | 4 studies | 28% ± 10% | |
| cardiac muscle cell | 4 studies | 16% ± 1% | |
| endothelial cell of lymphatic vessel | 4 studies | 25% ± 7% | |
| pericyte | 4 studies | 24% ± 10% | |
| microglial cell | 4 studies | 27% ± 6% | |
| retinal rod cell | 3 studies | 23% ± 4% | |
| ependymal cell | 3 studies | 32% ± 11% | |
| monocyte | 3 studies | 17% ± 1% | |
| lymphocyte | 3 studies | 26% ± 8% | |
| goblet cell | 3 studies | 35% ± 23% | |
| adipocyte | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1618.84 | 1445 / 1445 | 100% | 8.59 | 183 / 183 |
| ovary | 100% | 2381.67 | 180 / 180 | 100% | 8.85 | 429 / 430 |
| brain | 99% | 1257.20 | 2621 / 2642 | 100% | 7.87 | 703 / 705 |
| lung | 100% | 2183.27 | 577 / 578 | 99% | 6.88 | 1144 / 1155 |
| breast | 100% | 1882.07 | 459 / 459 | 99% | 11.01 | 1103 / 1118 |
| prostate | 100% | 1946.81 | 245 / 245 | 98% | 7.65 | 494 / 502 |
| intestine | 100% | 1785.20 | 966 / 966 | 96% | 5.17 | 508 / 527 |
| stomach | 100% | 1283.42 | 359 / 359 | 96% | 6.37 | 275 / 286 |
| uterus | 100% | 2426.22 | 170 / 170 | 96% | 6.39 | 440 / 459 |
| bladder | 100% | 1740.71 | 21 / 21 | 96% | 5.33 | 483 / 504 |
| pancreas | 100% | 832.94 | 328 / 328 | 96% | 4.88 | 170 / 178 |
| thymus | 100% | 1965.78 | 653 / 653 | 94% | 5.10 | 567 / 605 |
| skin | 100% | 1475.87 | 1808 / 1809 | 93% | 5.65 | 438 / 472 |
| kidney | 100% | 1099.88 | 89 / 89 | 91% | 5.11 | 817 / 901 |
| adrenal gland | 100% | 1217.51 | 258 / 258 | 77% | 3.13 | 178 / 230 |
| liver | 100% | 686.99 | 226 / 226 | 45% | 1.52 | 184 / 406 |
| adipose | 100% | 1764.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2126.43 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1328.79 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1721.66 | 241 / 241 | 0% | 0 | 0 / 0 |
| heart | 99% | 1277.61 | 854 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 7.19 | 42 / 45 |
| peripheral blood | 90% | 953.15 | 839 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 4.66 | 26 / 29 |
| eye | 0% | 0 | 0 / 0 | 64% | 2.38 | 51 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006325 | Biological process | chromatin organization |
| GO_0006281 | Biological process | DNA repair |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | EMSY |
| Protein name | BRCA2-interacting transcriptional repressor EMSY Alternative protein C11orf30 EMSY transcriptional repressor, BRCA2 interacting |
| Synonyms | C11orf30 GL002 |
| Description | FUNCTION: Regulator which is able to repress transcription, possibly via its interaction with a multiprotein chromatin remodeling complex that modifies the chromatin . Its interaction with BRCA2 suggests that it may play a central role in the DNA repair function of BRCA2 . Mediates ligand-dependent transcriptional activation by nuclear hormone receptors . . |
| Accessions | ENST00000524767.5 [Q7Z589-7] ENST00000524490.5 ENST00000531998.1 ENST00000695367.1 [Q7Z589-7] ENST00000532719.1 H0YCS3 ENST00000531793.1 ENST00000525919.5 [Q7Z589-5] E9PPE6 ENST00000334736.7 [Q7Z589-1] ENST00000533972.5 ENST00000529032.5 [Q7Z589-1] ENST00000533988.5 [Q7Z589-3] H0YET8 ENST00000524451.1 L8ECI5 ENST00000525038.5 [Q7Z589-4] ENST00000533248.5 [Q7Z589-6] H0YDI4 H0YEP9 E9PMC9 Q7Z589 |